SNYSanofi

Median target
$50
calls from the last 12 months
Implied return
+15.9%
median target vs. price
Coverage
6 analysts · 6 calls
updated in the last 12 months
Consensus
0/6/00 net
Buy / Hold / Sell

Which analysts are behind SNY's consensus?

See every current rating, price target and the analysts' track records for Sanofi — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 6 analysts with calls on SNY updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

SNY elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2025-09-11CongressLisa McClainMI-MI09Salesince trade -10.8%, vs market +27.7%$1K–$15K
2025-07-22CongressLisa McClainMI-MI09Salesince trade -12.9%, vs market +35.0%$1K–$15K
2025-06-17CongressLisa McClainMI-MI09Purchasesince trade -11.9%, vs market -40.8%$1K–$15K
2025-04-28ExecutiveLandau, ChristopherDeputy SecretarySaleSanofi (SNY)$15,001 - $50,000
2023-11-10CongressJohn JamesMI-MI10Purchasesince trade +0.7%, vs market -77.6%$1K–$15K
2022-05-27CongressEarl BlumenauerOR-OR03Purchasesince trade -13.0%, vs market -106.8%$15K–$50K
2022-03-16CongressJohn RutherfordFL-FL04Salesince trade -3.9%, vs market +89.3%$1K–$15K
2020-03-19CongressGreg GianforteMT-MT00Purchasesince trade +32.2%, vs market -214.4%$1K–$15K
2019-03-25CongressNicholas Van TaylorTX-TX03Salesince trade +27.2%, vs market +175.8%$15K–$50K
2018-12-03CongressJohn RutherfordFL-FL04Salesince trade +25.5%, vs market +180.3%$1K–$15K

More: congressional trades on SNY · insider activity · executive branch · trending